by Tom Ruginis | Dec 13, 2016 | Start-ups |
As 2016 draws to a close, we look back on two and half years of Perlara spending. Let’s begin with burn rate. This figure shows our monthly burn since first cash inflows in April 2014: In 2014, we completed model validation and assay development for our lead discovery...
by Ethan Perlstein | Oct 8, 2016 | Start-ups |
Last month at the 5th annual Global Genes Patient Summit, we announced our rebrand from Perlstein Lab PBC to Perlara PBC. Together with our partners at Valley Design Group, we created a new logo/mark that embodies the excitement and hope of scientific discovery. To go...
by Henry Perlstein | Jul 25, 2014 | Blogposts |
Incorporating as a Public Benefit Corporation (“PBC” or “Benefit Corp”) is more than mere symbolism and signaling – it is an enduring and emphatic statement about accountability, transparency and human ecology. By choosing to become a benefit...
by Ethan Perlstein | May 12, 2014 | Blogposts |
Hi, my name is Ethan. I’m the Founder and CEO of Perlstein Lab. Perlstein Lab is a biotech startup and public benefit corporation based in San Francisco. Our mission is precision (personalized) orphan disease drug discovery. In this inaugural post, I will briefly...
